Antibiotic Resistance: Strategic Solutions

Slides:

Advertisements

Similar presentations

HISPC-Illinois II The Public-Private Partnership Moves Forward on Privacy and Security.

Advertisements

Health literacy Impact and action at a national level 26 July, 2014 Nicola Dunbar Director, Strategy and Development.

Capability Cliff Notes Series PHEP Capability 2—Community Recovery What Is It And How Will We Measure It?

TRAINING FOR ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN HOSPITALS JUNE 2014.

Enhancing access to community clinical services July 2014.

Antimicrobial resistance “One health fits all”

Antibiotic Policy in Ghana; the way forward

Essential Drugs Programme

National MEDICAL HOME Autism Initiative 12/28/05.

STI Prevention & Control Programs Local and State M. Terry Hogan, MPH STD/HIV Prevention Training Center at JH June 9, 2014 National Center for HIV/AIDS,

TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.

Appropriate Use of Antibiotics A Veterinary Curriculum and Other Educational Activities Jennifer Nunnery, DVM ATPM Fellow FoodNet/NARMS Unit Foodborne.

Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.

Global and National Response to AMR Chatham House/Murdoch University AMR Symposium Chris Baggoley 8 December 2014.

Risk Management and NSQHS Standards, Standard 3 – Preventing and Controlling Healthcare Associated Infections Sue Greig Senior Project Officer National.

Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.

1 Mental Health as a Public Health Issue Daniel Reimer, MPH, Principal Investigator Sherwin Daryani, MPH, Project Director.

HRSA’s Oral Health Goals and the Role of MCH Stephen R. Smith Senior Advisor to the Administrator Health Resources and Services Administration.

A mixed model to promote rational use of medicines Nithima Sumpradit (1,2); Pisonthi Chongtrakul (3); Kunyada Anuwong (4); Somying Pumtong (4) 1: Food.

National MEDICAL HOME Autism Initiative Poster Presentation for DEC Conference 2005 Linda Tuchman Ginsberg, PhD

CDC’s Preemie Act Activities Wanda Barfield, MD, MPH, FAAP Director, Division of Reproductive Health National Center for Chronic Disease Prevention and.

Antibiotic Resistance Marc Siler Writing 39C The Strategies to Address Antimicrobial Resistance Act (STAAR Act)

The Antimicrobial Resistance Issue A briefing for the Secretaries Advisory Committee on Animal Health June 19, 2014.

Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.

The United Nations Global Initiative to Fight Human Trafficking (UN.GIFT) at the Informal Joint Briefing to Member States, Vienna, 2 March 2012.

The AMR One Health Policy Toolkit: Animal - Human Interface Dr Mark Schipp December 2014.

HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука

1 Combating Drug Resistance Syed Khalid Saeed Bukhari.

EC actions against the rising threats from Antimicrobial Resistance

The U. S. Health Care System Challenges, Opportunities and Solutions Fifth National HIPAA Summit Clinical Data Standards and the Creation of an Interconnected,

California Department of Public Health Office of AIDS HIV CARE and PREVENTION 2009: You Need to Know.

Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.

Georgia Comprehensive Cancer Control Program 3/10/2015 Program Monitoring and Evaluation Activities Short-Term Outcomes Long-Term Outcomes Intermediate.

Karen Harris Consultant in Emergency Medicine Chair of Sepsis Local Implementation Group.

ASEAN C OOPERATION ON H EALTH Health and Communicable Diseases Division ASEAN Secretariat.

IMCI Implementation in Ghana Initial assessment 1998 Adaptation phase ( ) Early implementation ( ): 4 focus districts Scale-up: 5-year.

Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.

U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.

An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.

Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.

Burden of Disease Research Unit (BOD) Towards a National Procedure Coding Standard for South Africa Lyn Hanmer Health Informatics R&D Co-ordination (HIRD)

ASTHO Prescription Drug Misuse and Abuse Strategic Map:

SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING AND RESULTS SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING.

Technological excellence

WHO’s prioritised research agenda for the prevention and control of NCDs prioritises

Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.

Evaluating Australia‘s National Strategy for Quality Use of Medicines

PRESENTATION OF MONTENEGRO

Task Force on Obesity Progress Report

UNESCO: More than Education!

Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.

Hypertension Control through 6|18 Interventions

Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.

Partnering with 12 community sectors:

Call topic identification for 2019 call

Antimicrobial Resistance: Plans for Korea and Beyond

EXPLORING GLOBAL COOPERATION OPPORTUNITIES

Health Partnerships SO Healthy Communities

Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”

TB Strategy & Health Systems (TBS) TB Monitoring & Evaluation (TME)

Technological excellence

Essential Drugs and Medicines Policy

Strategic Plan WESTERN REGION DRUG & ALCOHOL TASK FORCE

The Arizona Chronic Disease Plan:

Essential Drugs and Medicines Policy

CAMBODIA EXPERIENCES ON MTP (MONITORING-TRAINING-PLANNING) TO REDUCE INAPPROPRIATE MEDICINE USE IN HOSPITAL Prepared by Dr. Sok Srun and Dr. Chroeng Sokhan.

Workshop on the Revised WHO Guidance

The Rhode Island Department of Health (RIDOH)’s Strategic Priorities

Data Analysis and Reporting: Client Consultation & Strategic Recommendations Health Advocate’s annual reporting package includes developing customized.

Presentation transcript:

Antibiotic Resistance: Strategic Solutions Gordon W. Grundy, MD Regional Medical Director – Aetna Inc. July 19, 2005

Current National Activities Multiple independent initiatives – APUA, CAQH, AMA, AAP, AAFP, MCOs et al Public Health Campaign – Get Smart: Know When Antibiotics Work (2003) Healthcare Setting Campaign Interagency Task Force on Antibiotic Resistance (1999)

GET SMART: Know When Antibiotics Work

Prevent Antimicrobial Resistance in Healthcare Settings

Interagency Task Force on Antibiotic Resistance

A Public Health Action Plan to Combat Antimicrobial Resistance Part I: Domestic Issues Part II: Global Issues Focus Areas: 4 components Action Items: 84 initiatives

Domestic Action Plan Focus Areas Surveillance Prevention and Control Research Product Development

Action Plan Priority Initiatives With partners, design and implement a national AR surveillance plan. Develop and implement procedures for monitoring antimicrobial use in human medicine, agriculture, veterinary medicine and consumer products. In collaboration with many partners, develop and facilitate the implementation of educational and behavioral interventions that will assist clinicians in appropriate antimicrobial prescribing.

Action Plan Priority Initiatives Evaluate the effectiveness (including cost) of current and novel infection control practices for health care and extended care settings and in the community. Support demonstration projects to evaluate comprehensive strategies that use multiple interventions to promote appropriate drug use and reduce infection rates. In consultation with academia and the private sector, identify and conduct human clinical studies addressing AR issues of public health significance

Requirements for Strategic Success Awareness and understanding Commitment to Action Plan Multiple participants, public and private Multifaceted collaborative approach Comprehensive funding